Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of baloxavir marboxil plus neuraminidase inhibitor in hospitalized adults with influenza
2018-001416-30Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Baloxavir marboxil + neuraminidase inhibitor with Placebo + neuraminidase inhibitor (2 arms). Primary endpoint: Time to clinical improvement. Started Oct 2018; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on 2018-001416-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001416-30.